Evofem — Phexxi: House Rules
The first hormone-free contraceptive, launched as a permission slip to become queens of their own sex lives.
Real Chemistry — Senior Director, Strategy
Silver Cannes Lion · Gold CLIO · Shorty Award
The problem
A category running on resignation
Phexxi arrived FDA-approved and genuinely new — hormone-free, on demand, a mechanism of action the category had no shelf for. The obvious launch problem was education. The real one sat deeper: decades of limited and limiting options had taught women to stop asking for better.
The insight
Women are stuck in a trap of acceptance about their own reproductive health.
You can’t fix that with efficacy claims — acceptance isn’t a knowledge gap.
The move
Control as the product
House Rules skipped the mechanism lecture and sold what the mechanism actually buys: control. A disruptive, 360-degree launch built for sexually active women who set the rules of their own sex lives — birth control that shows up when she decides, on her terms, in her house. The science made the promise credible; the permission is what made it move.
Receipts
6 weeks after launch
+94%
New prescriptions
2B+
Earned impressions
#1
Most-followed pharma birth-control brand on Instagram
Dispensed units +82%
87.8MM social views at 9.7% engagement
2B+ earned reach including Ad Age, PR Week, and FiercePharma
Total prescriptions +81%
82.6K high-value actions, up 171% on 2% less spend
572K website sessions